1、林莉、王悦, STAT4的作用机制及其在疾病中的相关研究《细胞与分子免疫学》Vol.23(8):793-795,2007
2、王悦、李玉皓、李小洁、曾彬、张园、彭茜、杨荣存,体外抑制肿瘤JAK/STAT通路探讨STAT4对肿瘤免疫的影响《南开大学学报》(自然科学版)Vol.40(3)
2007
3、 李小洁、王悦,STAT1和STAT4在病原微生物感染中的防御作用《国外医学情报》Vol.27(11):12-14, 2006
4、 王悦, 常染色体隐性遗传的无丙种球蛋白血症 《国外医学 儿科学分册》Vol.32 (6): 372-374.2005
5、Jo EK. Wang Y. Kanegane H, et al. Identification of mutations in the
Bruton's tyrosine kinase gene, including a novel genomic rearrangements
resulting in large deletion, in Korean X-linked agammaglobulinemia
patients. J Hum Genet. Vol.48(6),:322-326. 2003
6、Kanegane H, Vilela MM, Wang Y, et al. Autoimmune lymphoproliferative
syndrome presenting with glomerulonephritis. Pediatr Nephrol.
Vol.18(5):454-456. 2003
7、Tani SM, Wang Y, Kanegane H,et al. Identification of mutations of
Bruton's tyrosine kinase gene (BTK) in Brazilian patients with XLA. Hum
Mutat. Vol.20(3):235-236,2002
8、Wang Y, Kanegane H, Sanal O, et al. A Novel Igalpha (CD79a) gene
mutation in a Turkish patient with B cell-deficient agammaglobulinemia.
Am J Med Genet. Vol.108(4):333-336,2002.
9、Wang Y, Kanegane H, Sanal O, et al. Bruton tyrosine kinase gene
mutations in Turkish patients with presumed XLA. Hum Mutat.
Vol.18(4):356-359,2002
10、Kanegane H, Futatani T, Wang Y. Nomura K, Shinozaki K, Matsukura H,
Kubota T, Tsukada S, Miyawaki T. Clinical and mutational characteristics
of XLA and its carrier identified by flow cytometric assessment combined
with genetic analysis. J Allergy Clin Immunol. V01.108(6): 1012-20. 2001
11、金兼弘和、筱崎健太郎、王悦、野村惠子、宫脇利男, 慢性活动性EB病毒感染症SAP/SH2D1A基因解析
《小儿感染免疫》V01.13(2):159-162,2001